Find NINDS Clinical Trials

Study Title Disorders Status Study Location Clinical Trials ID
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients Multiple Sclerosis Completed Maryland NCT00001669
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Completed Multiple U.S. Locations NCT00451204
A Futility Trial of Sirolimus in Multiple System Atrophy Multiple System Atrophy Terminated New York NCT03589976
A Multiple Ascending Dose Study of Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers Completed Maryland NCT04007263
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis Multiple Sclerosis Recruiting Maryland* NCT04025554
Analysis of the Nervous System in Patients With Fabry's Disease Completed Maryland NCT00001491
Assessment of Patients With Multiple Sclerosis (MS) Multiple Sclerosis, HTLV-1-Associated Myelopathy (HAM)/Tropical Spastic Paraparesis (TSP) Completed Maryland NCT00001156
Biomarkers in Multiple Sclerosis Multiple Sclerosis Completed Maryland NCT00325988
Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis Multiple Sclerosis Completed Maryland NCT00432900
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia Muscular Dystrophy Recruiting Multiple U.S. Locations NCT00912041
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Not Yet Recruiting Maryland* NCT05849467
Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis Multiple Sclerosis Recruiting Multiple U.S. Locations NCT04495556
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I Terminated Multiple U.S. Locations NCT00439218
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III Terminated Multiple U.S. Locations NCT00439569
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA) Recruiting Maryland* NCT04944940
Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx Completed Multiple U.S. Locations NCT00211887
Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO) Completed Maryland NCT01805024
Development of an Instrumented System to Measure Mobility in Parkinson's Disease Parkinson's Disease Completed Oregon NCT01174758
Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System Parkinson's Disease Completed Maryland NCT00001365
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study Multiple Sclerosis Recruiting Multiple U.S. Locations NCT04754542